title: Integrative tumor board: a case report and discussion from East-West Cancer Center.
abstract: OBJECTIVE
  To introduce the application of wheel balance cancer therapy (WBCT) in cancer treatment through an intensive study of a representative patient.
  
  
  METHODS
  A 59-year-old, female patient who was a secondhand smoker and who carried no significant medical and family history was diagnosed with T1N0M1 (stage 4) lung adenocarcinoma. Immunohistochemistry was positive for thyroid transcription factor-1, CK7, cyclin D1, p53, and Ki-67 on both lung biopsy specimens. An open lobectomy with mediastinal nodal dissection followed. The patient was transferred to East-West Cancer Center (EWCC) suffering from exertional dyspnea (NYHA [New York Heart Association] grade 2) with thoracic pain and pain in both upper limbs because of the decreased ventilatory capacity and reduced exercise capacity after a pulmonary resection. She also complained of emotional stress. EWCC provided WBCT, a multimodality alternative protocol based on the theory of traditional oriental medicine. Physicians regularly monitored whether metastasis or recurrence existed through blood and radiation tests. Observations and dialogues with the patient were used to record the changes in symptoms such as thoracic pain, dyspnea, anxiety, and fear.
  
  
  RESULTS
  Treatments at EWCC led to a disease-free survival of 28 months without adjuvant chemotherapy. Neither metastasis nor recurrence occurred during this period. Exertional dyspnea recovered to NYHA grade 1. Other physical and psychological symptoms were alleviated.
  
  
  CONCLUSIONS
  This report suggests that WBCT may have the potential for extending life expectancy, controlling symptoms, and improving quality of life in cancer patients.
authors.affiliation: East-West Cancer Center, Dunsan Oriental Medical Hospital of Daejeon University, Daejeon, Republic of Korea.
authors.forename: Hyo-Min
authors.initials: HM
authors.lastname: Park
authors.forename: Seo-Yeon
authors.initials: SY
authors.lastname: Kim
authors.forename: In-Chul
authors.initials: IC
authors.lastname: Jung
authors.forename: Yeon-Weol
authors.initials: YW
authors.lastname: Lee
authors.forename: Chong-Kwan
authors.initials: CK
authors.lastname: Cho
authors.forename: Hwa-Seung
authors.initials: HS
authors.lastname: Yoo
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000628:therapy*; D002173:Cancer Care Facilities; D000529:Complementary Therapies / Q000379:methods*; D019033:Delivery of Health Care, Integrated / Q000379:methods; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000628:therapy*; D055670:Medicine, Korean Traditional; D008875:Middle Aged; D009367:Neoplasm Staging; D011788:Quality of Life